Abstract
Introduction: Superior vena cava syndrome is described as the obstruction of blood flow through the superior vena cava. The literature reports that the incidence of this pathology varies from 1 case in every 650 inhabitants and 1 case in every 3 100 inhabitants. Since this condition is very rare in the pediatric population, no clear figure has been reported regarding its incidence in children. The use of a central venous catheter in newborns is a risk factor for this condition, as it may cause a thrombus due to the inflammatory reaction against the device. Therefore, it is necessary to initiate anticoagulation management and remove the catheter.Case presentation: Premature male newborn, (31.4 weeks gestation), with acute respiratory distress syndrome, early neonatal sepsis, pneumonia, necrotizing enterocolitis on 2 occasions, intestinal obstruction due to adhesions and intestinal volvulus. At 90 days of age, he presented thrombosis of the superior vena cava without involvement of the jugular and subclavian vein junction in the right atrium. Anticoagulant management was started, but given his unfavorable evolution, a multidisciplinary medical board was held to assess the risks, benefits, and treatment options in this age group. It was decided to start intracavitary tissue plasminogen activator treatment associated with mechanical thrombectomy and angioplasty of the superior vena cava. Due to the difficulty of conducting clinical trials in this population and the rates of major bleeding complications obtained with thrombolytic therapies, there is very little information available on the use of tissue plasminogen activator in newborns. For this reason, alteplase is seldom considered as the therapy of choice. However, in patients with life-threatening thrombosis, such as the present case, the results obtained in adults could be extrapolated in search of a favorable outcome.Conclusions: Fibrinolytic therapy is a way to reduce the size of the thrombus, but it dramatically increases the risk of bleeding; consequently, these patients must be strictly monitored. In pediatric populations, due to the diameter of the blood vessels, thrombectomy is difficult to perform; additionally, recurrent thrombosis and the need for transfusion of blood products are frequent.
Highlights
At 10 days of age, Superior vena cava syndrome (SVCS) is a he presented stage IIB necrotizing enterocolicomplication caused by the obstruction of blood tis, requiring access with a left central jugular flow through the superior vena cava
It should be noted that the management of include anticoagulant agents such as unfrac- SVCS in adults is extrapolated to the pediatric tionated heparin, low-molecular-weight heparin, population due to the lack of studies, being and thrombolytic therapy with r-TPA. thrombolytic therapy the treatment of choice
Thrombectomy is no longer one of the for example, Gray et al, [10] in a study first management options because the size of of 16 patients with central venous catheters the blood vessels limits the adequate approach who were treated with urokinase (n=11) or and makes this a procedure of high complexity streptokinase (n=5), reported that thrombolytic and morbimortality. [5]
Summary
Fibrinolytic therapy is a way to reduce the size of the thrombus, but it dramati- Premature male patient (31.4 weeks of gestacally increases the risk of bleeding; consequent- tion), Caucasian and from the municipality of ly, these patients must be strictly monitored. At 32, 42, 56 jugular and subclavian vein junction in the right and 82 days of age, the patient required surgery atrium For this reason, it was decided to initito manage a new intestinal perforation, peritonitis, ate anticoagulation with low-molecular-weight intestinal obstruction due to adhesions and intestinal heparin considering the high risk of paradoxical volvulus, respectively. At 210 days of age, the patient, who was not develop subsequent complications, his still in nutritional recovery, was discharged from condition did not improve, and face and neck hospital with the indication of treatment with edema persisted · Thrombolysis with alteplase + mechanical thrombectomy + angioplasty + femoral central venous catheter placement Broad-spectrum antibiotic
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
